Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. MarketScreener Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Mesoblast Limited
  6. Summary
    MSB   AU000000MSB8

MESOBLAST LIMITED

(MSB)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
04/12/2021 04/13/2021 04/14/2021 04/15/2021 04/16/2021 Date
2.23 2.26 2.28 2.3 2.32 Last
1008095 1564518 1354079 1560750 1581129 Volume
0.00% +1.35% +0.88% +0.88% +0.87% Change
Financials
Sales 2021 65,5 M 50,6 M 50,6 M
Net income 2021 -83,9 M -64,8 M -64,8 M
Net cash position 2021 130 M 100 M 100 M
P/E ratio 2021 -19,1x
Yield 2021 -
Sales 2022 49,4 M 38,2 M 38,2 M
Net income 2022 -138 M -106 M -106 M
Net Debt 2022 13,7 M 10,6 M 10,6 M
P/E ratio 2022 -12,8x
Yield 2022 -
Capitalization 1 524 M 1 179 M 1 178 M
EV / Sales 2021 21,3x
EV / Sales 2022 31,1x
Nbr of Employees 102
Free-Float 84,2%
More Financials
Company
Mesoblast Limited is engaged in the development of regenerative medicine products. The Company’s regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells. Its allogeneic, off-the-shelf cell product candidates target advanced stages of diseases with high and unmet medical needs. The Company’s portfolio of Phase III product candidates comprises RYONCIL... 
More about the company
Notations Surperformance© of Mesoblast Limited
Trading Rating : Investor Rating :
More Ratings
All news about MESOBLAST LIMITED
04/07MESOBLAST  : Maxim Group Upgrades Mesoblast to Buy From Hold, Sets $18 Price Tar..
MT
04/05MESOBLAST  : Director's Interest Notice - Appendix 3X
PU
03/30MESOBLAST  : Operational Highlights and Upcoming Milestones
PU
03/29MESOBLAST  : Philip J. Facchina, Chief Strategy Officer and Principal of SurgCen..
AQ
03/28MESOBLAST  : Director Appointment/Resignation
PU
03/14MESOBLAST  : Prospectus for Warrants in Connection with US$110M Raise
PU
03/10MESOBLAST LIMITED  : - MSB Closes US$110M Raise Led By US Strategic Investor Gro..
AQ
03/10MESOBLAST LIMITED  : - Notice under Section 708A(5)(e) of the Corporations Act 2..
AQ
03/08MESOBLAST  : Raises $110 Million Via Private Placement
MT
03/08Mesoblast Closes US$110/A$138 Million Financing Led by US Strategic Investor ..
GL
03/08MESOBLAST  : MSB Closes US$110M Raise Led By US Strategic Investor Group
PU
03/08MESOBLAST  : Cleansing Notice and Appendix 2A
PU
03/04MESOBLAST LIMITED  : - Notice under Section 708A(5)(e) of the Corporations Act 2..
AQ
03/02MESOBLAST  : Completes US$110/A$138 Million Financing Led by US Strategic Invest..
AQ
03/02MESOBLAST  : Raises $110 Million from Share Placement
MT
More news
News in other languages on MESOBLAST LIMITED
2020EN DIRECT DES MARCHES  : Renault, Vivendi, EssilorLuxottica, Kering, Vinci, Micr..
2020MÄRKTE ASIEN/Corona-Sorgen lassen Anleger vorsichtig agieren
2020Aktien Schweiz: Wenig verändert - Anleger unschlüssig
2020MÄRKTE ASIEN/Wenig veränderte Börsen mit positiver Tendenz
2020Principales informations avant-Bourse
More news
Analyst Recommendations on MESOBLAST LIMITED
More recommendations
Chart MESOBLAST LIMITED
Duration : Period :
Mesoblast Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MESOBLAST LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 5,87 AUD
Last Close Price 2,32 AUD
Spread / Highest target 528%
Spread / Average Target 153%
Spread / Lowest Target -55,5%
EPS Revisions
Managers and Directors
NameTitle
Silviu Itescu Chief Executive Officer, MD & Executive Director
Joshua Muntner Chief Financial Officer
Joseph R. Swedish Independent Non-Executive Chairman
Paul Simmons Head-Research & New Product Development
Fred Grossman Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
MESOBLAST LIMITED3.11%1 179
MODERNA, INC.53.03%68 414
LONZA GROUP AG-1.16%45 120
IQVIA HOLDINGS INC.20.31%41 337
CELLTRION, INC.-14.21%37 693
SEAGEN INC.-16.92%26 380